Results 111 to 120 of about 178,708,228 (184)

Chinese Guideline on Risk Management of Osteoporosis in the General Public

Orthopaedic Surgery, Volume 18, Issue 10, Page 2015-2031, October 2026.
Summary of the background, key recommendations, and expected impact of the public guideline for osteoporosis risk management. ABSTRACT Background Osteoporosis is a common chronic skeletal disorder characterized by decreased bone mass and microarchitectural deterioration, resulting in increased fragility and fracture risk. With rapid population aging in
Shiyong Zhang, Jinqiu Yuan, Zhuojing Luo, Jiacan Su, Weibo Xia, Kehu Yang, Fuxin Wei, Osteoporosis Group, Chinese Association of Orthopaedic Surgeons, Youth Osteoporosis Group, Chinese Orthopaedic Association, Chinese Medical Association, Health Communication Branch, Chinese Preventive Medicine Association, Spine and Joint Health Branch, Guangdong Health Care Association, Chinese Health Risk Management Collaboration–Osteoporosis Group (CHRIMAC‐OP), Zhuojing Luo, Jiacan Su, Weibo Xia, Kehu Yang, Fuxin Wei, Jinqiu Yuan, Xiao Chen, Bo Gao, Yang Guo, Xiaofeng Gong, Junjie Huang, Yafang Huang, Tianyong Hou, Da He, Bin Liu, Yajun Liu, Fangping Li, Ying Li, Wei Li, Jiang Li, Zhihao Li, Xiahong Lin, Houqing Long, Jianwen Mo, Wenfei Ni, Yuanjun Teng, Liang Wang, Xiaobin Wang, Hongli Wang, Nan Wu, Hongfei Xiang, Bin Yan, Dejin Yang, Min Yang, Wei Ye, Hongping Yu, Ziji Zhang, Shiyong Zhang, Xinyu Chen, Ningning Chen, Qiangsheng He, Linmin Hu, Wenjing Li, Zijun Li, Qiji Li, Chengkai Lin, Qingfeng Luo, Tianyi Liu, Ningning Mi, Mina Ma, Jun Shen, Peng She, Huidong Tian, Siqing Wu, Junming Wan, Yongsheng Wang, Bin Xia, Peng Xie, Jinyu Zhao, Fei Zhang, Penghui Zhang, Danni Wang, Lei Cheng, Zhongshi Li, Xinyu Liu, Jing Wang, Shengping Yang, Binsheng Yu   +84 more
wiley   +1 more source

Osteonecrosis of the jaw associated with the use of oral biphosphonates: apropos five cases [PDF]

, 2020
Summary Osteonecrosis of the jaw is a disease which needs to be taken into account whenever there is exposure of bone as a secondary result of any dental operation in a patient who has been taking biphosphonates over a long period of time.
Arjona Giménez C, Dios Navarrete, J, AB Marín Fernández   +3 more
core  

Experimental study of the effect of teriparatide on a medication-related rat model of osteonecrosis of the jaw

Kouqiang hemian waike zazhi
[Objective:] To establish a stable model of medication-related osteonecrosis of the jaw (MRONJ), and to explore the therapeutic effect of teriparatide on MRONJ.
LIAO Chenyu, XU Luchen, LI Yunfeng
doaj   +1 more source

Dental implants in oral rehabilitation after denosumab and bisphosphonate-related osteonecrosis of the jaw in a young patient: an unusual case

Journal of Oral Medicine and Oral Surgery
Patients often request oral rehabilitation after surgical resection. Here, a 19-year-old patient developed medication-related osteonecrosis of the jaw after treatment with antiresorptive therapy.
Salabert Noémie, Loison-Robert Ludwig, Ahossi Victorin, Hoarau David   +3 more
doaj   +1 more source

Actinomycosis and osteonecrosis of the jaw : every why hides a why

, 2021
Actinomycosis and osteonecrosis of the jaw : every why hides a ...
25TH CONGRESS OF THE EUROPEAN ASSOCIATION FOR CRANIO MAXILLO FACIAL SURGERY - EACMFS 2021, Magremanne, Michèle, Arnal Etienne, Andrea, Van Eeckhout, Pascal   +3 more
core  

Successful radiofrequency thermocoagulation of the mandibular nerve for intractable pain associated with medication-related osteonecrosis of the jaw: a case report

JA Clinical Reports
Background Bisphosphonates may cause serious adverse events, including osteonecrosis of the jaw. This article describes a case of successful application of radiofrequency thermocoagulation for pain caused by osteonecrosis of the jaw. Case presentation An
Sho Shinotsuka, Aiko Maeda, Tomoka Eri, Nozomi Kameyama, Chiaki Yamada, Masako Asada, Ken Yamaura   +6 more
doaj   +1 more source

Osteonecrosis of the jaw during sorafenib therapy for hepatocellular carcinoma

, 2016
Introduction: Sorafenib is an oral multiple tyrosine kinase inhibitor and is currently the only evidence-based treatment recommended for advanced hepatocellular carcinoma.
CAMELLI, VITTORIA, SPINARDI, LUCA, TREVISANI, FRANCO, GARUTI, FRANCESCA, BUCCI, LAURA   +4 more
core   +1 more source

Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients

, 2010
Osteonecrosis of the jaw (ONJ), previously an entity associated with radiation therapy to the head and neck, has been observed in patients treated with bisphosphonates. Patients with metastatic breast cancer and myelomatous bone disease, commonly treated
GAGEL, Robert F., Gabriel N. Hortobagyi, HOFF, Ana O., Ana O. Hoff, TOTH, Bela, Mimi Hu, HU, Mimi, Bela Toth, Robert F. Gagel, HORTOBAGYI, Gabriel N.   +9 more
core   +1 more source

Case Report: Development of medication-related osteonecrosis of the jaw in a patient on long-term infliximab therapy

Frontiers in Oral Health
Medication-Related Osteonecrosis of the Jaw (MRONJ) is a challenging and evolving aspect of Oral and Maxillofacial Surgery. In recent years, several medications apart from those traditionally associated with MRONJ such as bisphosphates (BPs) and ...
Derek Oryniak, Meagan Brown, Lillie Cholakis, Reda Elgazzar   +3 more
doaj   +1 more source

Bisphosphonate-Related Osteonecrosis of the Jaw

, 2017
Introduction: Bisphosphonates are efficiently used to treat osteoporosis, bone metastases of malignant tumors, Paget`s disease and multiple myeloma. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) represents a severe side effect, consisting of ...
Kolarov, Rossen, Dobrev, Desislav, Toncheva, Borislava, Rachev, Daniel   +3 more
core   +1 more source